Denardo GL - Search Results

1

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.

Denardo GL, Denardo SJ, Kukis DL, O'Donnell RT, Shen S, Goldstein DS, Kroger LA, Salako Q, Denardo DA, Mirick GR, Mausner LF, Srivastava SC, Meares CF. Denardo GL, et al. Among authors: denardo sj, denardo da. Anticancer Res. 1998 Jul-Aug;18(4B):2779-88. Anticancer Res. 1998. PMID: 9713461 Clinical Trial.

2

Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.

DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. DeNardo SJ, et al. Among authors: denardo gl. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3938S-44S. Clin Cancer Res. 2003. PMID: 14506192

3

Documentation of idiotypic cascade after Lym-1 radioimmunotherapy in a patient with non-Hodgkin's lymphoma: basis for extended survival?

Bradt BM, DeNardo SJ, Mirick GR, DeNardo GL. Bradt BM, et al. Among authors: denardo sj, denardo gl. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):4007S-12S. Clin Cancer Res. 2003. PMID: 14506201

4

Strategies for enhancement of radioimmunotherapy.

DeNardo G, DeNardo S, Kukis D, Diril H, Suey C, Meares C. DeNardo G, et al. Int J Rad Appl Instrum B. 1991;18(6):633-40. doi: 10.1016/0883-2897(91)90033-h. Int J Rad Appl Instrum B. 1991. PMID: 1743986

5

Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1.

DeNardo GL, DeNardo SJ, O'Grady LF, Levy NB, Adams GP, Mills SL. DeNardo GL, et al. Among authors: denardo sj. Cancer Res. 1990 Feb 1;50(3 Suppl):1014s-1016s. Cancer Res. 1990. PMID: 2297713

6

Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.

Deshpande SV, DeNardo SJ, Meares CF, McCall MJ, Adams GP, Moi MK, DeNardo GL. Deshpande SV, et al. Among authors: denardo sj, denardo gl. J Nucl Med. 1988 Feb;29(2):217-25. J Nucl Med. 1988. PMID: 3258025 Free article.

7

Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.

DeNardo GL, Lamborn KR, DeNardo SJ, Goldstein DS, Dolber-Smith EG, Kroger LA, Larkin EC, Shen S. DeNardo GL, et al. Among authors: denardo sj. Cancer Res. 1995 Dec 1;55(23 Suppl):5893s-5898s. Cancer Res. 1995. PMID: 7493366

8

Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions.

Richman CM, DeNardo SJ, O'Grady LF, DeNardo GL. Richman CM, et al. Among authors: denardo sj, denardo gl. Cancer Res. 1995 Dec 1;55(23 Suppl):5916s-5920s. Cancer Res. 1995. PMID: 7493370

9

Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1.

De Nardo GL, Kroger LA, Mirick GR, Lamborn KR, De Nardo SJ. De Nardo GL, et al. Int J Biol Markers. 1995 Apr-Jun;10(2):67-74. doi: 10.1177/172460089501000201. Int J Biol Markers. 1995. PMID: 7561241 Clinical Trial.

10

Radioimmunotherapy of lymphoma: a UC Davis experience.

Lewis JP, Denardo GL, Denardo SJ. Lewis JP, et al. Among authors: denardo sj, denardo gl. Hybridoma. 1995 Apr;14(2):115-20. doi: 10.1089/hyb.1995.14.115. Hybridoma. 1995. PMID: 7590765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters